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Title: Clinical and bacteriological profile in lymph node and bone tuberculosis. 
Aims and objectives: 
1.  To study the clinical data and histopathological and microbiological correlates in 
clinical suspects of lymph node and bone tuberculosis. 
2. To study the pattern of drug resistance in microbiologically confirmed cases of lymph 
node and bone tuberculosis. 
Materials and Methods:  
114 patients with clinical suspicion of  spine(31) and lymph node tuberculosis(83) in whom 
treating doctor(pulmonologist, general surgeon, orthopaedician) has suggested surgical 
intervention for diagnostic/therapeutic reasons were enrolled in the study after obtaining 
informed consent. The clinical history regarding present complaints, past history of anti-
tuberculous treatment (ATT) and co-morbidities  were taken.  Investigations including 
complete hemogram, antibody test for HIV, Random Blood Sugar, Chest X ray were done for 
all patients. Other investigations were done as clinically indicated. Preoperative evaluation 
was done and patients were posted for surgery after obtaining fitness from anaesthetist. 
Surgical specimens including excision biopsy specimens, pus, bone debris were obtained  and 
were sent for histopathological examination to pathology lab and for AFB smear examination 
by Ziehl Neelson method, AFB solid culture in LJ medium and drug susceptibility  
testing(DST) by 1% proportion method  to National Reference Laboratory, National Institute 
for Research in Tuberculosis, Chetpet, Chennai. 
  
 
Results  
We defined a case of lymph node and bone tuberculosis if granulomas were present in 
histopathology or if LJ culture showed growth and identified as Mycobacterium tuberculosis 
or both. The case definition based on histology and microbiology was met by 86.8%(99/114) 
of clinical suspects of lymph node and bone tuberculosis.  Most of the patients of lymph node 
tuberculosis were in the age group of 11-20 years and of bone tuberculosis were in the age 
group of 31-40 years. Lymph node tuberculosis was more common in females with a male to 
female ratio of 3:5 and bone tuberculosis  more common in males with a male to female ratio 
of 2:1. There was histopathological evidence of granulomas in 80%(91/114) of clinical 
suspects of lymph node and bone tuberculosis. Mycobacterium tuberculosis was isolated 
from 26.2% (26/99)of clinical suspects of lymph node and bone tuberculosis.  Of the culture 
isolates 23% showed non granulomas in histology, of these 60% were HIV seropositive and 
40% diabetic. It is inferred that immune suppression interferes with eliciting a granulomatous 
response and hence in patients with immune suppression tuberculosis should be considered 
even in the absence of granulomas in histology. The multi drug resistant rate is 22% in 
previously treated patients compared to none of the new patients. The resistance rate in HIV 
patients is 37.5% and in HIV negative patients is 27.7%. 
 Conclusion 
In our study we observed the culture yield to be low due to paucibacillary nature of the 
disease in concordance with earlier studies. In immune compromised state like HIV and 
diabetes nongranulomatous histology in lymph node and spine TB were noted. Lymph node 
and bone tuberculosis have a higher degree of drug resistance in previously treated patients 
and HIV seropositive patients. These groups can be considered as risk factors for drug 
resistance in lymph node and bone tuberculosis and can be targeted for drug susceptibility 
testing(DST). 
Key words:- extra pulmonary tuberculosis, tuberculous lymphadenitis, Pott’s spine, drug 
resistant tuberculosis, multi drug resistant tuberculosis, LJ culture. 
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INTRODUCTION 
Scourge, phthisis, phyma, hectic fever, consumption, white death, white 
plague, struma, the names are plenty and also notoriously described by John 
Bunyan as ‘captain of all men of death’ is the disease tuberculosis known to 
man since time immemorial. The fight against tuberculosis has been fought for 
ages. The disease has taken its toll on humans since long and continues to do 
so.  
Tuberculosis is an ancient infection that has plagued humans throughout 
history. It has been referred to in the Vedas as ‘rajayakshma’.  There is clear 
evidence to show that the infection existed dating back to 8000 B.C., from 
skeletal remains of prehistoric humans in Germany.1,2 
Tuberculosis is one of the leading causes of mortality in India killing 2 
persons every three minutes, nearly 1000  every day.3 
The clinical manifestations of tuberculosis are of two types: Pulmonary 
and Extra-pulmonary forms of tuberculosis(EPTB), pulmonary being the 
commonest. 
Extra pulmonary tuberculosis is defined as tuberculosis of organs other than the 
lungs, such as pleura, lymph nodes, abdomen, genito-urinary tract, skin, joints, 
bones, tubercular meningitis, tuberculoma of the brain, etc.4 Diagnosis is based  
on atleast one specimen with  confirmed Mycobacterium tuberculosis from the 
extrapulmonary site; or histological evidence; or strong clinical evidence 
2 
 
consistent with active extra pulmonary tuberculosis disease followed by a 
medical officer’s decision to treat with a full course of anti-tuberculous 
therapy.4,5 
As tuberculosis infection is spread by aerosol, pulmonary tuberculosis is 
the most common  form of the disease. Extra pulmonary tuberculosis is usually 
a consequence or accompaniment of pulmonary tuberculosis.  
The problem of drug resistant tuberculosis has been recognised since the 
advent of the first anti tuberculous drug. The problem of drug resistance is now 
a major hindrance in our war against this centuries old disease. According to 
global TB report 2014, 3.5% of new patients and 20.5% of previously treated 
patients have multidrug resistant tuberculosis (MDR-TB). In 2013, an 
estimated 4,80,000 new cases of MDR-TB were reported globally, and 
approximately 2,10,000 deaths  were reported due to  multidrug resistant 
tuberculosis    (MDR-TB).   More than half of MDR TB patients were in India, 
China and the Russian Federation. Extremely drug resistant tuberculosis  
(XDR-TB) is reported in 9% of patients with multidrug resistant tuberculosis 
(MDR-TB).6 
The main focus of international and national control strategies is on 
pulmonary tuberculosis it being the transmissible form of disease. However 
extra pulmonary tuberculosis including lymph node and bone tuberculosis adds 
significantly to the burden of disease and requires early, accurate diagnosis. 
Prompt diagnosis is hindered by the difficulty in obtaining adequate, 
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representative samples, high rates of contamination, lack of gold standard 
diagnostic tests and the low yield of conventional cultures. There is a need for 
large multi centric epidemiologic trials to study the risk factors and patterns of 
drug resistance in extra pulmonary tuberculosis and direction of resources 
towards high risk individuals for drug susceptibility testing. 
Much of the reported data worldwide is on pulmonary tuberculosis, 
hence we undertook this study to analyse the clinical and bacteriological 
charecteristics in extrapulmonary tuberculosis confining ourserlves to lymph 
node and bone tuberculosis in particular spine tuberculosis. 
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REVIEW OF LITERATURE 
Extra pulmonary tuberculosis constitutes 15-20% of total cases of 
tuberculosis in immune hosts and 50% of total cases of  tuberculosis in immune 
compromised hosts.7 The most common site of involvement of extra 
pulmonary tuberculosis is lymph node, followed by pleural effusion.8 
The clinical presentation of extra pulmonary tuberculosis is atypical and 
includes a wide array of differential diagnosis. It is difficult to obtain samples 
for diagnosis and the yields are poor by conventional methods. For managing 
complications and for diagnosis, surgical means may be required to procure 
tissue samples.8 
Pulmonary tuberculosis being the main transmissible form of 
tuberculosis has received the main focus in international control strategies. 
Extra pulmonary tuberculosis also significantly contributes to the burden of 
disease and hence requires special attention.9 
On analysing the reasons for incorrect estimation of extra pulmonary 
tuberculosis, difference in terminology was found to be an important reason. 
Some authors included pleural tuberculosis as a form of extra pulmonary 
tuberculosis while others considered lungs and the covering pleura to be a 
single organ and ascribed both organs to pulmonary tuberculosis.9 
In a descriptive analysis done in European Union(EU)/ European 
Economic Area(EEA) to study the burden and trends of extra pulmonary 
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tuberculosis by Sandgren et al., in 2013 notification rates of tuberculosis from 
2002 to 2011 decreased due to decrease in pulmonary tuberculosis but for extra 
pulmonary tuberculosis the notification rates remained stable[3.4/100000 in 
2002 and 3.2/100000 in 2011]. Hence they inferred that proportion of extra 
pulmonary tuberculosis showed a rising trend from 2002(16.4%) to 
2011(22.4%). In their study 33.7% cases of extra pulmonary tuberculosis were 
culture confirmed. They concluded that while pulmonary tuberculosis showed a 
falling trend, extra pulmonary tuberculosis showed a rising trend.10 
A negative smear for acid fast bacillus, negative culture and absence of 
granulomas does not rule out the diagnosis of extra pulmonary tuberculosis.11 
Golden MP et al., suggested high clinical index of suspicion in absence of 
diagnostic proof and absence of alternate diagnosis favours the diagnosis of 
tuberculosis. 
Excisional biopsy of lymph nodes with its histopathology, smear for 
Acid Fast Bacillus and Lowenstein-Jensen culture are the diagnostic tests of 
choice for lymph node tuberculosis. Fine needle aspiration is more reliable in 
HIV seroreactive patients because of high bacillary load.12 
 Hematological manifestations are common in extrapulmonary disease 
due to systemic involvement by dissemination. Anemia, increased or decreased 
leucocyte counts, increased or decreased platelets, monocytosis and rarely 
pancytopenia are associated with extrapulmonary tuberculosis.13 
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Positive findings in chest x ray or positive tuberculin skin test supports the 
diagnosis but negative results do not rule out extrapulmonary tuberculosis.14 
Shadows suggestive of healed tuberculous lesion are present in chest 
roentgenograms of approximately 50% of  patients with osteoarticular 
tuberculosis but active pulmonary tuberculosis is rare.15 
The diagnosis of peritoneal, urogenital and meningeal tuberculosis is 
more difficult due to wide options of differential diagnosis and low sensitivity 
of diagnostic tests both conventional and Polymerase Chain Reaction(PCR) 
based tests.8 
The radiological differential diagnosis of most forms of extrapulmonary 
tuberculosis includes metastatic disease and low grade pyogenic infections like 
brucellosis, fungal infections and sarcoidosis.14 Lymph nodes showing 
peripheral rim enhancement and low attenuation centres are more commonly 
seen in tuberculosis but are also seen in lymphoma, inflammatory conditions 
and metastatic malignancies.16 
Drug Resistant Tuberculosis: 
Drug resistance is defined as temporary or permanent capacity of 
organisms and their progeny to stay viable or multiply in presence of drug 
concentrations that would destroy or inhibit growth normally. 
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Types of drug resistance: 
1. Primary:  
Drug resistance in patients without previous history of treatment 
for tuberculosis, possibly their source of infection being drug resistant 
cases. 
2. Acquired: 
Patients who were infected with drug sensitive bacilli, but later 
developed resistance to one or more of the drugs. Acquired drug 
resistance is usually due to inappropriate regimens, inadequate dosages 
and non adherence by patients.17 
The thought of antibiotic resistance against drugs was first recognised 
shortly after the discovery of streptomycin in 1944, when they observed that a 
substantial proportion of patients treated with streptomycin had a relapse 
following an apparent cure. The phenomenon of fall of susceptible organisms 
followed by a rise of resistant organisms was appreciated leading to the 
recommendations for multi drug therapy. 
Abdulrahman A Alrajhi et al, observed that young age and history of 
past treatment with tuberculosis drugs were risk factors among patients with 
drug resistant tuberculosis.18 
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Gneya Bhatt et al., observed that prior history of lost to follow up and 
poor socioeconomic conditions were risk factors for drug resistant 
tuberculosis.19 
Girma Mulisa et al., reported history of contact with a case of 
tuberculosis, alcohol abuse, farming by occupation, retroviral disease and 
previous treatment as risk factors for drug resistant tuberculosis.20 
 Lymph Node Tuberculosis: 
Lymph node tuberculosis, the most common form of extra pulmonary 
tuberculosis was known as the King’s evil during the Middle Ages. It was 
believed that royal touch cured scrofula and the gift of gold coin from the king 
prevented further scrofulous attacks.21 Historically lymph node TB is more 
common in children.  
 Multiplicity, matting and caseation are the three clinching points 
favouring the diagnosis of tuberculous lymphadenitis. If the offending node is 
below the deep fascia through which it may break through it results in a 
subcutaneous caseous collection (collar-stud abscess). As the disease process 
reaches the surface, skin gets involved producing scrofuloderma or tuberculous 
dermatitis. 
Lymph node tuberculosis may be a part of primary or post primary 
disease. In children with lymph node TB 50-80% have radiographic evidence 
of active pulmonary tuberculosis which is in concordance with Walgren’s 
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calendar for primary tuberculosis published in 1948. In striking contrast in 
adults with tuberculous lymphadenitis only 30% show chest x ray abnormality 
and the abnormality is usually of old healed tuberculous lesion and the lymph 
node disease is part of post primary or reactivation disease. Walgren’s 
calendar22 depicting the sequence of events in primary tuberculosis is presented 
below. 
Stage Duration Features 
1 3-8 weeks 
The primary complex 
develops. Conversion to 
tuberculin positivity 
occurs. 
2 About 3 months 
Life threatening forms of 
disease due to 
hematogenous 
dissemination occur i.e. 
tuberculous meningitis 
and military tuberculosis. 
3 3-4 months 
Tuberculous pleurisy 
may be the result of 
either hematogenous 
spread or direct spread 
from an enlarging 
primary focus. 
4 Up to 3 years 
This stage lasts until the 
primary complex 
resolves. More slowly 
developing extra 
pulmonary lesions, 
particularly in the bones 
and joints, may appear. 
5 Up to 12 years 
Genitourinary 
tuberculosis may occur 
as a late manifestation of 
primary tuberculosis. 
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In the West historically lymph node TB was caused mainly by 
mycobacterium bovis but in India the cirucumstances are different. The habit of 
consuming boiled milk and cows being relatively immune to the tuberculosis of 
the udder, Mycobacterium  tuberculosis  causes nearly all cases of tuberculous 
lymphadenitis. 
Mediastinal nodes inspite of being the primary draining sites, account 
for less than 5% cases of reported lymph node TB. Clinically apparent 
tuberculous lymphadenitis commonly involves nodes of head and neck. 
Infection in these nodes commonly results from generalised lymphatic spread 
from a primary lung infection, since localised primary infections are unusual in 
head and neck. 
The possible events in lymph node TB are compression of surrounding 
tissue, caseation, breakdown and healing of eroded nodes causing fibrotic 
remnants. Even though mortality is uncommon, morbidity and chronic illness is 
common.  
In general tuberculous lymphadenitis is most common in cervical 
region, but inguinal, axillary, mediastinal, mesenteric and intramammary 
involvement also occurs.23 
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The common sites of tuberculous lympadenitis in head and neck region 
are 
1. Anterior and posterior cervical 
2. Submandibular 
3. Preauricular  
4. Submental 24 
The differential diagnosis includes chronic septic lymphadenitis, 
Hodgkin’s disease, secondary carcinomatous deposits.  
Symptoms of tuberculous lymphadenitis:25 
1. Painless, slowly progressive swelling 
2. Weight loss 
3. Temperature elevation 
4. Anorexia 
5. Fatigue 
6. Malaise 
7. Pain 
8. Ulcer or sinus(if chronic) 
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Tuberculosis of bone: 
Bone and joint tuberculosis accounts for up to 35% of all 
extrapulmonary tuberculosis. Skeletal tuberculosis is most common in the 
spine, followed by tuberculous arthritis of hip and knee and extraspinal 
tuberculous osteomyelitis.15 
Tuberculosis of the spine was first described by Sir Percival Pott in 
1782, and hence spinal tuberculosis is called Pott’s spine.26 Spinal TB accounts 
for 50% of the cases of skeletal TB. 
Pott’s disease most commonly involves thoracic spine. Intervertebral 
disc involvement from antero-inferior part of vertebral body results in anterior 
wedging and disc space obliteration causing gibbus.(palpable spinal 
prominence). Spinal involvement is due to hematogenous spread of 
Mycobacterium tuberculosis to the cancellous bone of the vertebral bodies. The 
site of primary infection is usally a pulmonary or genitourinary infection 
The common presenting symptoms includes local pain, constitutional 
symptoms and paraplegia secondary to cord compression. The most common 
symptom is back pain localised to the site of disease most commonly in the 
thoracic region. The intensity of pain varies among different persons from mild 
dull aching pain to severe excruciating pain. The pain may be aggravated by 
movements of the spine, weight bearing and coughing. 
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In skeletal tuberculosis, arthrocentesis and synovial fluid mycobacterial 
cultures, synovial biopsy and bone biopsy for mycobacterial culture and 
histopathological examination are diagnostic investigations.27 
The pathological changes28 in the spine includes, 
1. Central type of vertebral body involvement 
2. Para-discal lesion 
3. Anterior type of involvement of vertebral bodies 
 
Dr.Prabakar et al.,in their study  in 1989 comparing ambulatory 
treatment with chemotherapy and radical surgery with chemotherapy concluded 
that operative intervention is not needed  in the great majority of patients and 
reported a favourable status of 97% at three years with nine months 
chemotherapy with isoniazid and rifampicin. Over the years the indications for 
surgery in tuberculosis spine has evolved.29 
 Paraplegia is the most common indication for surgical intervention in 
Pott’s spine.  
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The other indications includes the following:30 
Indications for surgery without neurological involvement 
Progressive bone destruction in spite of ATT 
Failure to respond to conservative therapy 
Evacuation of paravertebral abscess when it has increased in size despite 
medical treatment 
Uncertainty of diagnosis, for biopsy 
Mechanical reasons:spinal instability caused by destruction or collapse, 
destruction of two or more vertebrae, kyphosis 
Prevention of severe kyphosis in young children with extensive dorsal lesions 
Large paraspinal abscess 
 
Indications for surgery with neurological involvement30 
New or worsening neural complications or lack of improvement with 
conservative treatment 
Late onset paraplegia 
Neural arch disease 
Spinal tumor syndrome(epidural spinal tuberculoma without osseous 
involvement) 
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Causes of early onset paraplegia in Pott’s spine:30 
Mechanical pressure 
 
 
Mechanical pressure by tuberculous 
debris, sequestrum of bone or disc, 
abscess, subluxation and dislocations, 
concertina collapse and internal 
gibbus. 
Tuberculous granuloma Tuberculoma in extradural, intradural, or intramedullary regions. 
Tuberculous myelitis Uncommon. May involve spinal cord parenchyma. 
Spinal artery thrombosis Infective thrombosis of spinal artery 
Tuberculous arachnoiditis Meningeal inflammation and fibrosis 
 
Causes of late onset paraplegia in Pott’s spine:30 
 
Transection of spinal cord by bony 
bridge 
Transverse ridge of bone produced by 
severe kyphosis. 
Fibrosis of dura(pachymeningitis) Formation of tough, fibrous 
membrane encircling the cord. 
 
Litao Li et al., analysed retrospectively 35 cases of drug resistant spinal 
tuberculosis. 12 out of the 35 cases were multi drug resistant(MDR) and 23 did 
not meet the criteria for multi drug resistance. They reported that 33 out of the 
35 cases were cured following surgery and chemotherapy guided by results of 
drug susceptibility testing(DST) and remained disease free at final follow up.( 
nearly 3 years follow up was done)31 
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Lan Xu et al, analysed 19 patients of drug resistant spinal tuberculosis of 
which 16  patients had multidrug resistant tuberculosis and 3 patients had non 
multi drug resistant tuberculosis. They reported that all of their study 
population were cured following surgical intervention(open surgery and 
percutaneous drainage with local chemotherapy) and remained disease free at 
final followup(2 years)32 
Laboratory Diagnosis: 
The diagnostic challenges in extrapulmonary tuberculosis includes lack 
of adequate amount or volume of samples, the samples being divided into 
portions for several diagnostic tests(histology, cytology, biochemistry, 
microbiology) resulting in non uniform distribution of organisms and the 
paucibacillary nature of the disease.33 
Histopathological Examination: 
Granuloma is a focal collection of inflammatory cells in a compact manner in 
which mononuclear cells predominate. Granuloma is the histological hallmark 
of tuberculosis and tuberculosis is described as the proto type of granulomatous 
inflammation. Granulomas contain the spread of infection by the active 
involvement of numerous enzymes and cytokines. Granulomas are the result of  
delayed type hypersensitivity or persistent organisms. 
The granulomas seen in active tuberculosis are soft or exudative 
granulomas which contain acid fast bacill and are not well circumscribed, 
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whereas the granulomas seen in healed tuberculosis are hard or proliferative 
granulomas which are well circumscribed and usually do not contain acid fast 
bacilli. 
The various etiological agents for granulomatous response includes: 
Mycobacteria Tuberculosis, leprosy, Buruli ulcer, 
swimming pool granuloma 
Bacteria Brucellosis, meliodosis, actinomycosis, 
nocardiosis,granuloma 
inguinale,listeriosis, tularaemia 
Chlamydiae Lymphogranuloma venereum, trachoma 
Rickettsiae Q fever 
Spirochetes Syphilis, pinta, yaws 
Fungi Cryptococcosis, candidiasis, 
sporotrichosis,histoplasmosis, 
aspergillosis, 
blastomycosis,coccidiodomycosis, 
chromoblastomycosis, mycetoma 
Protozoa Leishmaniasis, toxoplasmosis 
Nematodes Visceral larva migrans 
Trematodes Schistosomiasis, 
paragonimiasis,fascioliasis,clonorchiasis 
Viruses Infectious 
mononucleosis,cytomegalovirus, 
measles,mumps 
Foreign body Talc,silica 
Bacterium Cat scratch disease 
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Microbiological examination: 
The lack of diagnostic gold standard makes the situation complex. The 
various diagnostic modalities for demonstration for organisms includes smear 
for acid fast bacillus, culture methods and molecular analysis. 
The processing of extra-pulmonary specimens require milder 
decontamination methods since they are paucibacillary. It is necessary to 
inoculate onto multiple media such as LJ, LJ slopes, SK medium enriched with 
sodium pyruvate (SP) to get better culture yield.34 
The lack of gold standard for diagnosis for extrapulmonary tuberculosis 
is striking in the metaanalysis comparing various diagnostic standards against 
Xpert MTB/RIF by Stephen D Lawn et al,35  
Torticoli et al., in 2012 in their study in Italy37 used  
1. culture(both solid and liquid) or  
2. suggestive radiology/histology with documented positive response to 
tuberculosis treatment as gold standard. 
Armand et al., in 201138 from France used culture in both solid and 
liquid media as gold standard.(n=32) 
Causse et al., from Spain in 201139  included tissue biopsies, CSF, 
gastric aspirates, pleural fluid, purulent exudates in their analysis and used 
solid and liquid media culture as gold standard.(n=41) 
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Friedrich et al., from South Africa in 201140  used liquid culture as gold 
standard in their analysis. 
Hillemann et al., from Germany in 201141  used solid and liquid culture 
as gold standard for tuberculosis diagnosis in samples of tissue, gastric aspirate 
and urine in their analysis. 
Ligthelm et al., from South Africa in 201142 used a composite gold standard 
of  
1. positive cytology + AFB and/or 
2. Culture of MTB 
Moure et al., from Spain43  in their analysis of lymph node, abscess 
aspirates, lymph nodes and pleural fluid used solid and liquid culture as the 
gold standard. 
In India, Vadwai et al, in 201144  used a composite gold standard of 
1. Smear 
2. Culture 
3. Clinical 
4. Radiology and 
5. Histology 
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In another study by A K Maurya et al., in 2012 used BACTEC culture as 
the gold standard in their analysis of samples from multiple extra pulmonary 
sites.36 
In the studies which used solid and liquid culture as the sole gold 
standard criterion for diagnosis have a lower positivity rate. And the ideal gold 
standard would be a combination of clinical, microbiological and clinical 
response to tuberculosis treatment in follow up. 
The atypical clinical presentation, wide differential diagnosis and 
difficulty in procuring adequate representative sample for microbiological and 
histopathological examination and lack of uniform diagnostic criteria has been 
a hurdle in prompt diagnosis of disease and huge variation in epidemiological 
data from different regions of the world. 
A K Maurya et al., in 201236 reported patterns of drug resistance in extra 
pulmonary tuberculosis in North India. In their study they included 756 patients 
with clinical diagnosis of extra pulmonary tuberculosis of various sites 
including lymph node tuberculosis, cold abscess, pleural fluid, genitourinary 
tuberculosis, ascitic fluid, biopsy materials, pus, pericardial fluid, synovial fluid 
and bone marrow aspirates.  Of the clinical suspects of extra pulmonary 
tuberculosis 30.1%(n=165) were positive for mycobacteria by BACTEC 
culture. They included only the culture positive cases for further analysis. 
74.5% of their study population were new patients(no treatment or less than 
one month of treatment against tubercle bacilli) and 25.5%  had previous 
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history of treatment, history of contact was present in 25.4% of patients,11.5% 
patients were having a history of diabetes mellitus and 1.8% of cases were HIV 
positive. 
They subjected the culture isolates for drug susceptibility testing for first 
line anti-tuberculous drugs including isoniazid, rifampicin, ethambutol and 
streptomycin. They observed higher presence of resistant strains in patients 
with history of prior treatment with antituberculous drugs. 61.8% of new cases 
were susceptible to all drugs and 57.2% of previously treated cases were 
susceptible to all drugs. They observed that monoresistance and resistance to 
two drugs were more common in new cases whereas resistance to three drugs 
and resistance to four drugs were more common in previously treated cases. 
They observed that on the whole 39.9% of extrapulmonary tuberculosis cases 
were resistant to first line anti-tubercular drugs. 
Among the resistant cases, they found multi drug resistant 
tuberculosis(MDR-TB) to be present in 13.5% of cases of extrapulmonary 
tuberculosis. They considered that the reason for this high rate of multi drug 
resistant tuberculosis(MDR-TB) could be due to the fact that chronic cases 
with high suspicion of drug resistance were subjected to drug susceptibility 
testing (DST) in their tertiary care hospital. 
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AIMS OF THE STUDY 
1. To study the clinical data and histopathological correlates in clinical 
suspects of lymph node and bone tuberculosis. 
2. To study the microbiological pattern in clinically suspected cases of 
lymph node and bone tuberculosis. 
3. To study the pattern of drug resistance in microbiologically confirmed 
cases of lymph node and bone tuberculosis. 
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MATERIALS AND METHODS 
 
Study design: Prospective Observational Study. 
Study Period:  March 2014 – August 2014. 
Inclusion criteria: 
1. Patients clinically suspected as lymph node/bone tuberculosis in whom 
treating doctor has suggested surgical intervention for 
histopathological/microbiological diagnosis/therapeutic reasons in 
Thoracic  Medicine/General Surgery/Orthopaedics departments at Rajiv 
Gandhi Government General Hospital, Chennai. 
2. Patient with/without history of previous anti-tuberculous treatment. 
3. Patients seropositive/seronegative for human immunodeficiency virus. 
4. Patients with/without pulmonary tuberculosis. 
5. Patients willing to participate in the study. 
Exclusion Criteria: 
1. Patients clinically suspected as lymph node/bone tuberculosis in whom 
the treating doctor has not suggested histopathological/microbiological 
diagnosis/therapeutic interventions. 
2. Patients currently on anti tuberculous therapy for more than 2 weeks. 
3. Patients not willing to participate in the study. 
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Sample Size :  
114 patients who attended outpatient department of Thoracic 
Medicine/General Surgery/Orthopaedic departments of Rajiv Gandhi 
Government General Hospital satisfying inclusion/exclusion criteria were 
enrolled in the study. 
Methodology: 
84 consecutive patients who presented with lymph node enlargement in 
superficial lymph node groups (cervical/axillary/inguinal) and suspected as 
lymph node tuberculosis by the treating doctor and were referred for surgical 
excision for diagnostic/therapeutic reasons were included in the study. 
31 consecutive patients who presented with clinical and radiological 
features consistent with tuberculous spodylitis and surgical management 
suggested by treating doctor for diagnostic/therapeutic reasons were included 
in the study. 
The patients included in the study were admitted in the hospital after 
explaining about the study in detail and obtaining informed consent. Detailed 
clinical history including 
1. Presenting complaints 
2. Duration of symptoms 
3. History of constitutional symptoms 
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4. History of contact with sputum positive case of tuberculosis 
5. Previous history of treatment for tuberculosis/ history of diabetes 
mellitus and other comorbid illness was obtained. 
General examination and structured clinical examination were done as 
relevant for the case. 
Routine investigations including 
1. Chest  X ray PA view 
2. Hemogram 
3. Random Blood Sugar 
4. HIV antibody testing were done for all patients. 
Other investigations including 
 Fasting Blood Sugar 
 Postprandial Blood Sugar 
 Renal Function Test 
 Liver Function Test 
 Sputum for Acid Fast Bacilli 
 Ultrasonogram Abdomen/Neck 
 X ray Lumbo sacral/dorsal spine 
 MRI Spine were done as warranted by clinical situation. 
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Pre operative evaluation was done and patients were posted for surgery 
after obtaining anaesthetic fitness. Cardiology clearance was obtained in 
patients greater than 40 years of age. 
In lymph node tuberculosis suspects, excision of  lymph nodes was done 
under local/general anaesthesia. Skin crease incision was made and lymph 
nodes excised in toto. The sample was divided into two. One portion was sent 
in formalin container to the pathology lab. The other portion was sent in 
Kirschner’s medium to National Reference Labarotory, National Institute for 
Research in Tuberculosis (NIRT), Chetpet, Chennai on the same day of surgery 
for direct smear examination for AFB, Lowenstein-Jensen (LJ) culture and 
Drug Susceptibility Testing (DST). 
In bone tuberculosis suspects, pus, bone debris specimens from site of 
pathology were divided into two. One portion was sent for histopathological 
examination and the other portion sent to NIRT for direct smear examination 
for AFB, LJ culture and DST. 
Extra pulmonary specimens in general are paucibacillary in nature and 
hence their processing methods require milder decontamination. Hence the 
specimens are inoculated into media made selective by incorporating 
polymyxin B, amphotericin B, carbenicillin, vancomycin and trimethoprim to 
inhibit growth of other microorganisms (PACT). 
The tissue specimens are cut into small pieces using sterile scissors and 
transferred into a sterile tissue grinder tube and homogenised with 5 ml of 
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sterile water. A direct smear is made from the homogenate.  The smear is 
prepared and read using modified Ziehl-Neelson method. 
The homogenate is centrifuged for 15 minutes and the supernatant 
decanted.  5% sulphuric acid solution is added to the deposit and centrifuged at 
3500 rpm for 15 minutes. After discarding the supernatant the deposit is mixed 
with 0.2 ml sterile water and inoculated onto two slopes of Lowenstein – 
Jensen media and incubated at 37 degree Celsius. 
 The cultures are read weekly and typical colonies of Mycobacterium 
tuberculosis are rough, buff, tough, nonpigmented (cream coloured) and slow-
growers i.e. Colonies appearing after one or two weeks after inoculation.  
Niacin test, inhibition by paranitrobenzoate and catalase test are done for 
species identification. Mycobacterium tuberculosis yield positive niacin test 
(pink colour), positive catalase test (bubbles seen) and inhibited by 
paranitrobenzoate (PNB). 
Drug susceptibility is tested by 1% proportion method. Resistance is 
defined as mycobacteria with greater than 1% of the population exhibiting 
growth in the presence of the lowest concentration of drug tested.34 
In this method suspension of growth is prepared by scrapping 
representative sample into 0.3 ml of sterile distilled water and a uniform 
suspension made and kept aside for coarser particles to settle down. Serial 
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dilutions are made from this suspension by adding 0.2 to 1.8 ml of sterile water 
[10-1(S1),10-2(S2),10-3(S3)..]   
Concentrations of drugs used in drug susceptibility testing (DST): 
Dihydrostreptomycin : 4 µg/ml  
Isoniazid   : 0. 2 µg/ml  
Rifampicin   : 40 µg/ml  
 Ethambutol   : 2 µg/ml 
The results were interpreted based on 42-day readings. If there was 
clear-cut resistance based on the 28-day reading the results are reported as 
such. Strains susceptible at 28 days were read again at 42 days and reported 
based on the later reading only.  
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Figure 1: Illustration of 1% proportion method 
The colonies growing on drug containing medium inoculated with the 
10 -1 dilution that equal or more the number of colonies growing on the control 
medium (drug free medium) inoculated with the 10-3 dilution suggests 1% or 
more of the test population. If the calculation was 1% or more then results 
interpreted as resistance34. 
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Definitions: 
1. H/O contact: 
A person exposed to M. tuberculosis infection by sharing air space with a 
case of sputum positive pulmonary tuberculosis at household or 
workspace. 
2. Anemia:  
Anemia is defined as haemoglobin concentration less than 13 
grams/decilitre in males and less than 12 grams/decilitre in females. 
3. Elevated Erythrocyte Sedimentation Rate(ESR): 
ESR greater than 40 mm per hour is defined as high ESR. 
4. Constitutional symptoms: 
History of fever, loss of appetite, loss of weight( as perceived and 
reported by the patient) of more than two weeks duration. 
5. Diabetes mellitus: 
Fasting blood sugar greater than 126 mg/decilitre and/or random blood 
glucose greater than 200 mg/decilitre. 
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6. Case of  lymph node/bone tuberculosis: 
A patient is defined as having lymph node/ bone tuberculosis if either 
granulomas are present in histopatology or LJ culture shows growth and 
identified as Mycobacterium tuberculosis or both. 
7. New case: 
A new case of  lymph node/bone tuberculosis is defined as a patient of 
lymph node/bone tuberculosis who has not received anti tuberculosis 
drugs previously or taken anti tuberculosis drugs of less than 4 weeks 
duration. 
8. Previously treated case: 
A previously treated case of lymph node/bone tuberculosis is defined as a 
patient of lymph node/bone tuberculosis who has received more than 4 
weeks of anti tuberculous drugs. 
9. HIV: 
A patient is defined as HIV seropositive if he/she tests positive by rapid 
HIV antibody test and confirmed by a second antibody test. 
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10. Granuloma 
The granuloma consists of blood-derived macrophages, epithelioid cells 
and Langhans giant cells surrounded by T lymphocytes with or without 
necrotic centers. 
11. Smear positive for AFB: 
Direct smears prepared after homegenisation of the sample were 
processed using modified Ziehl-Neelson technique and reported as 
positive according to WHO grading scale. 
12. Culture positive for Mycobacterium tuberculosis: 
Homogenised specimen inoculated on Lowenstein-Jensen slopes and 
reported as positive and identified as Mycobacterium tuberculosis by 
biochemical tests. 
13. Resistance to first line antituberculous drug: 
The subcultures inoculated on drug free and drug containing media in 
suspensions of serial dilutions and reported as resistant by 1% 
proportion method. 
Statistical analysis: 
Statistical analysis was done using the SPSS software. Significance of 
correlation between variables was assessed using p value. A correlation was 
considered to be statistically significant if its p value is less than 0.05.  
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OBSERVATION AND RESULTS 
We diagnosed lymph node tuberculosis and bone tuberculosis if either 
granulomas were present in histopathology or LJ culture showed growth and 
identified as mycobacterium tuberculosis or both. 
 
Figure 2 – Diagnosis of lymph node tuberculosis and bone tuberculosis. 
We diagnosed 19 cases as tuberculous based on both granulomas in 
histopathology and growth in LJ medium identified as Mycobacterium 
tuberculosis, 73 cases based on granulomas  in histopathology alone and 7 
cases based on LJ culture alone. 
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Out of 114 clinical suspects of lymph node and bone tuberculosis, 99 
were diagnosed as tuberculous, lymph node(n=74) and bone(n=25). 
 
Figure 3 : Diagnosis of lymph node tuberculosis 
 
Figure 4: Diagnosis of bone tuberculosis 
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Our study included 114 patients of clinical suspects of lymph node 
(n=83) and bone tuberculosis (n= 31). 
 
Figure 5– Histopathological patterns in clinical suspects of lymph node 
and bone tuberculosis. 
Out of the 114 patients 92 patients had granulomas , 12 patients had non 
specific inflammation, 5 patients had carcinoma, 3 patients had lymphoma, 1 
patient had acute inflammation and 1 patient had necrotic tissue on 
histopathological examination of the biopsy specimens. 
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We observed that LJ culture showed growth and isolates identified as 
Mycobacterium tuberculosis in 26 cases out of 114 cases. 
 
Figure 6 – LJ culture showing growth of Mycobacterium tuberculosis. 
 
Figure 7 – Comparison of histopathological pattern and AFB culture. 
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Out of 92 patients with granulomas on histopathology 19 were positive 
in LJ culture and out of 22 patients with non granulomas on histopathology 7 
were positive in LJ culture. 
 
Figure 8: HPE Granuloma 
       
 
Figure 9:HPE non granuloma 
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Supportive evidence in lymph node and bone tuberculosis versus 
other diagnosis 
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Tuberculosis  24  75  80  10  60  39  85  14  
Other 
diagnosis 3  12  12  3  9  6  13  2  
 
Table 1 : Supportive evidence in tuberculous versus other diagnosis 
We analysed the contributions of contact history, constitutional 
symptoms, anemia and elevated ESR in the clinical suspicion of lymph node 
and bone tuberculosis. 
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Contact History 
 
Figure 10: History of contact in tuberculous versus other etiologies 
History of contact was present in 24 % of patients with tuberculosis. 
Constitutional symptoms 
Figure 11: Constitutional symptoms in tuberculosis versus other etiologies 
Constitutional symptoms were present in 81% of patients with tuberculosis. 
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Anemia 
 
Figure 12: Anemia in tuberculosis versus other etiologies 
Anemia was present in 60% of patients with tuberculosis. 
Elevated ESR 
 
Figure 13: Elevated ESR in tuberculosis versus other etiologies 
Elevated ESR was present in 86% of patients with tuberculosis. 
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Supportive evidence in diagnosis of lymph node and bone 
tuberculosis 
 
Figure 14: Role of supportive evidence in diagnosis of tuberculosis 
We observed that history of contact was present in 24 % of patients with 
tuberculosis and 20% of patients with non tuberculous etiology. We observed 
that constitutional symptoms were present in 81% of patients with tuberculosis 
and 80% of patients with other etiologies. 
We observed that anemia was present in 60 % of patients with 
tuberculosis and 60 % of patients with other etiologies and elevated ESR in    
86 % of patients with tuberculosis and 87 % of patients with other diagnosis.  
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Age distribution 
Age 
Distribution 
- Lymph 
Node Vs 
Bone TB  
Lymph Node 
TB  
%  Bone TB  %  
11-20 Years  35  47.29  0  0  
21-30 Years  30  40.5  8  32  
31-40 Years  1  1.35  10  40  
41-50 Years  2  2.70  4  16  
51-60 Years  6  8.10  2  8  
61-70 Years  0  0  1  4  
Total  74  100  25  100  
 
Table 2 – Age distribution in lymph node and bone tuberculosis 
The peak age distribution observed in lymph node tuberculosis is 11 -20 
years (47.29%), closely followed by 21-30 years (40.5%). These two age 
groups together constitute nearly 88% of cases of lymph node tuberculosis in 
our study.  
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 The peak age distribution that we observed in bone tuberculosis is 31-
40 years (40%), followed by 21-30 years (32%). These two age groups 
constitute 72% of cases of bone tuberculosis. 
 
Figure – 15: Age distribution in lymph node and bone tuberculosis 
Both lymph node and bone tuberculosis is relatively less common in age 
greater than 40 years. We observed that only 10% of lymph node tuberculosis 
occurs in age greater than 40 years and 24% of bone tuberculosis occurs in age 
greater than 40 years.  
Age Distribution - Lymph Node Vs Bone TB Lymph Node TB Bone TB 
N 74 25 
Mean 25.06 35.26 
SD 14.02 12.04 
P value Unpaired t Test 0.000289 
 
Table -3: Mean age in lymph node and bone tuberculosis 
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Figure 16– Lymph node tuberculosis age distribution 
The mean age of occurrence of lymph node tuberculosis in our study is 25 years. 
 
Figure 17– Bone tuberculosis age distribution 
The mean age of occurrence of bone tuberculosis in our study is 35 years. 
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Gender distribution 
Gender 
Distribution 
Lymph Node 
TB % Bone TB % 
Male 27 36.48 15 60 
Female 47 63.51 10 40 
Total 74 100 25 100 
P value 
Fishers Exact Test 0.011 
 
Table 4: Gender distribution in lymph node and bone tuberculosis. 
 
Figure 18: Gender distribution in lymph node and bone tuberculosis. 
We observed a female preponderance in lymph node tuberculosis 
(63.51%) and male preponderance in bone tuberculosis (60%) which is 
statistically significant [p value -0.011] 
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Figure 19: Gender distribution in lymph node tuberculosis 
In our study the ratio of male : female patients in lymph node 
tuberculosis is 3 : 5.3. 
 
Figure 20 : Gender distribution in bone tuberculosis 
We observed a male: female ratio of 3 : 2 in bone tuberculosis. 
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Sites of involvement in lymph node tuberculosis 
Site of involvement Number of cases 
Anterior cervical 31 
Posterior cervical 35 
Submandibular 4 
Axillary 3 
Inguinal 1 
 
Table 5 : Sites of involvement in lymph node tuberculosis 
 
Figure  21: Lymph node tuberculosis-sites of involvement 
In our study, we observed that posterior cervical lymph node 
involvement was seen in 35 cases, anterior cervical in 31 cases, submandibular 
in 4 cases, axillary in 3 cases and inguinal in 1 case. 
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Sites of involvement in bone tuberculosis 
Site of disease Number of cases 
Upper thoracic disease(above D4) 1 
Lower thoracic disease(below D4) 17 
Lumbar disease 7 
 
Table 6: Bone tuberculosis(spine) – sites of involvement 
 
Figure 22: Spine tuberculosis – sites of involvements 
We observed 17 cases of bone tuberculosis in lower thoracic spine, 6 
cases in lumbar spine and 2 cases in thoracic spine. 
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Contact History 
Contact History 
Status  New Cases  %  
Previously 
Treated 
Cases  
%  
Contact History 
present  22  27.16  2  11.1  
Contact History 
absent  59  72.83  16  88.88  
Total  81  100  18  100  
P value  
Fishers Exact Test  0.1513  
 
Table 7: History of contact with sputum positive pulmonary 
tuberculosis in new and previously treated patients 
 
Figure 23: Contact History among new and previously treated patients 
In our study we observed that 27% new patients and 11.1% previously 
treated patients had history of contact with sputum positive case of pulmonary 
tuberculosis. 
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Constitutional Symptoms 
Constitutional Symptoms  
New 
Cases  
%  
Previously 
Treated 
Cases  
%  
Constitutional Symptoms  
present  
71  87.65  18  100  
Constitutional Symptoms  
absent  
10  12.34  0  0  
Total  81  100  18  100  
P value  
Fishers Exact Test  0.4594  
 
Table 8: Constitutional symptoms in new and previously treated patients 
 
Figure 24: Constitutional symptoms in new and previously treated patients 
We observed that constitutional symptoms were present in 71 out of 81 
new patients(87.65%) of lymph node and bone tuberculosis and in all the 
previously treated patients. 
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Anemia 
Anaemia 
Status  New Cases  %  
Previously 
Treated Cases  %  
Anaemic  49  60.49  11  61.11  
Not Anaemic  32  39.50  7  38.88  
Total  81  100  18  100  
P value  
Chi Squared Test  0.6522  
 
Table 9: Anemia(Hb<13 g/dl in males and Hb<12 g/dl in females) in new 
and previously treated patients of lymph node and bone tuberculosis 
Figure 25: Occurence of anemia among new and previously treated 
patients of lymph node and bone tuberculosis 
 
We observed that 60% of new patients and 61.1% of  previously treated 
patients of lymph node and bone tuberculosis had haemoglobin concentration 
of less than 12 gram/dl. 
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Elevated ESR 
ESR Status  New Cases  %  
Previously 
Treated 
Cases  
%  
ESR > 40 mm/hr  69  85.18  16  88.88  
ESR ≤ 40 mm/hr  12 27.16  2  11.11  
Total  81  100  18  100  
P value  
Fishers Exact Test  
0.1513  
 
Table 10: ESR >40 mm Hg in new and previously treated patients 
 
Figure 26: Elevated ESR in new and previously treated patients 
In our study, we observed that 85%(n=85) of patients of lymph node and 
bone tuberculosis had ESR>40 mm Hg. 
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Smear for Acid Fast Bacillus 
Smear 
Status  New Cases  %  
Previously 
Treated Cases  %  
Smear +ve  6  7.41  6  33.33  
Smear -ve  75  92.59  12  66.67  
Total  81  100  18  100  
P value  
Chi Squared Test  0.0066  
 
Table 11: Direct Smear for AFB in new and previously treated patients 
 
 
 
 
 
 
Figure 27: Direct Smear for AFB in new and previously treated patients 
We observed that 7% of new patients(6 out of 81) and 33% of 
previously treated patients(6 out of 18)  had positive smear for acid fast 
bacillus by modified Ziehl- Neelson staining and the difference is statistically 
significant.[p=0.0066] 
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LJ Culture 
LJ Culture 
Status  New Cases  %  
Previously 
Treated Cases  %  
Culture 
positive  17  20.98  9  50  
Culture 
negative  63  77.77  9  50  
Total  81  100  18  100  
P value  
Chi Squared Test  0.0055  
 
Table 12: LJ culture results in new and previously treated patients 
 
Figure 28: LJ culture results in new and previously treated patients 
In our study 9 out of 18(50%) previously treated patients had positive 
culture in LJ medium and identified as mycobacterium tuberculosis. 17 out of 
81(20.98%) of new patients had positive culture and the difference is 
statistically significant.[p=0.0055] 
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Drug Susceptibility Testing 
DST Results  New Cases  %  Previously Treated Cases  %  
P value 
Fishers 
Exact Test  
Sensitive  14  82.35  4  44.44  
0.0781  Resistant  3  17.64  5  55.55  
Total  17  100  9  100  
 
Table 13: Drug Susceptibility testing in new and                    
previously treated patient 
 
 
 
 
 
 
Figure 29: Drug Resistance in new and previously treated patients 
In our study 14 patients out of 17 new patients had drug sensitive 
tuberculosis and 4 out of 9 previously treated patients. The drug resistance is 
17.6% in new and 55.5 % in previously treated patients. 
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Figure 30: DST pattern (first line antituberculous drugs) 
Out of 26 patients with culture positive results, 18 patients had drug 
sensitive tuberculosis. Among the 8 patients who had drug resistant 
tuberculosis, 2 had multidrug resistance (resistance to isoniazid and rifampicin) 
2 had poly drug resistance (resistance to more than one antituberculous drug 
other than combination of isoniazid and rifampicin) and 4 had mono drug 
resistance (resistance to only one first line antituberculous drug). 
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Diabetes  Mellitus 
Diabetes Mellitus Status  New Cases  %  Previously Treated Cases  %  
Diabetes Mellitus +  9  11.11  0  0.00  
Diabetes Mellitus -  72  83.95  18  100.00  
Total  81  100  18  100  
P value  
Fishers Exact Test  0.1252  
 
Table 14: Diabetes mellitus in new cases and previously treated cases 
 
Figure 31: Diabetes mellitus in new cases and previously treated cases 
In our study population 16% of the new cases had diabetes and none of 
the previously treated cases had diabetes. 
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Constitutional symptoms in diabetics and non diabetics 
DM Vs 
Constitutional 
Symptoms  
Constitutional 
Symptoms Present  
Constitutional 
Symptoms Absent  
Column 
Total  
Diabetic  5  4  9  
Non Diabetic  84  6  90  
Row Total  89  10  99  
P value Fishers Exact Test  0.0012  
 
Table 15: Constitutional symptoms in diabetics versus non diabetics 
 
Figure 32: Constitutional symptoms in diabetics and non diabetics 
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Figure 33: Percentage of diabetics and non diabetics with 
constitutional symptoms 
We observed constitutional symptoms in 5 out of the 9 diabetic patients 
in our study. Among the non diabetics, out of 90 patients 84 had constitutional 
symptoms.  
We observed constitutional symptoms to be present in 55.55% of 
diabetics and 93.33% of non diabetics. There is a difference in the occurrence 
of constitutional symptoms in patients of lymph node and bone tuberculosis if 
diabetes is a co morbid illness and the difference is statistically 
significant.[p=0.0012] 
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Smear for Acid fast bacilli and diabetes mellitus 
DM Vs Smear 
Positivity  
Smear positive  Smear Negative  Column Total  
Diabetic  1  8  9  
Non Diabetic  11  79  90  
Row Total  12  87  99  
P value Fishers Exact Test  > 0.9999  
 
Table 16: AFB smear positivity in diabetics and non diabetics 
 
Figure 34: AFB smear positivity in diabetics and non diabetics 
We observed that in 1 out of patients 9 diabetics direct smear for AFB 
was positive and in 11 out of 90 non diabetics direct smear for AFB was 
positive. 
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Comparison of culture growth and diabetes mellitus 
DM Vs Culture 
Positivity  Culture Positive  
Culture 
Negative  Column Total  
Diabetic  3  6  9  
Non Diabetic  23  67  90  
Row Total  26  73  99  
P value Fishers Exact Test  > 0.9999  
 
Table 17: Comparison of growth in culture and diabetes mellitus 
 
Figure 35: Co-relation between growth in culture and diabetes mellitus 
We observed that 3 out of 9 diabetic patients (33.33%) had 
mycobacterium tuberculosis grown in culture and 23 out of 90 non 
diabetics(25.55%) had positive growth in LJ culure. 
 
62 
 
Drug resistance pattern in diabetics and non diabetics 
DM Vs Drug 
Resistance  Drug Sensitive  Drug Resistant  Column Total  
Diabetic  2  1  3  
Non Diabetic  16  7  23  
Row Total  18  8  26  
P value Fishers Exact Test  > 0.9999  
 
Table 18: Drug resistance pattern in diabetics and non diabetics 
 
Figure 36: Drug resistant pattern in diabetics and non diabetics 
We observed that out of 3 diabetic patients who had growth in culture 2 
patients had drug sensitive tuberculosis and 1 patient had drug resistant 
tuberculosis. 
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HIV seropositivity in new and previously treated patients 
HIV Status  New Cases  %  
Previously 
Treated Cases  
%  
HIV +ve  7  8.64  3  16.66  
HIV  -ve  74  91.35  15  83.33  
Total  81  100  18  100  
P value  
Fishers Exact Test  
0.3767  
 
Table 19: HIV seropositivity in new and previously treated patients 
 
 
 
 
 
Figure 37: HIV seropositivity in new and previously treated patients 
In our study, there were 7 HIV seropositive patients among new patients 
and 3 HIV seropositive patients among previously treated patients of  lymph 
node and bone tuberculosis. 
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Constitutional symptoms in HIV patients 
HIV Positivity Vs 
Constitutional 
Symptoms  
Constitutional 
Symptoms Present  
Constitutional 
Symptoms Absent  
Column 
Total  
HIV Positive  8  2  10  
HIV Negative  81  8  89  
Row Total  89  10  99  
P value Fishers Exact Test  0.3188  
 
Table 20: Constitutional symptoms in HIV seropositive  
and seronegative patients 
 
 
 
 
 
Figure 38 : Constitutional symptoms in HIV seropositive and 
seronegative patients 
In our study 8 out of 10 HIV patients (80%) had constitutional 
symptoms and 81 out of 89 non HIV patients(91.01%) had constitutional 
symptoms. 
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Granulamotous histopathology in HIV and non HIV patients 
HIV Positivity Vs 
HPE Positivity  
HPE 
Granuloma  
HPE non 
granuloma  Column Total  
HIV Positive  4  6  10  
HIV Negative  88  1  89  
Row Total  92  7  99  
P value Fishers Exact Test  0.0057  
 
Table 21: Granulomas  in HIV and non HIV patients 
 
Figure 39: Granulomas in HIV and non HIV patients 
In our study out of 10 HIV patients, 6(60%) did not show granulomas in 
histopathology. Among 89 patients who are seronegative for HIV 1(0.01%) did 
not show granuloma in histopathology. 
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Direct AFB smear in HIV and non HIV patients 
HIV Positivity Vs 
Smear Positivity  
Smear positive  Smear Negative  Column Total  
HIV Positive  4  6  10  
HIV Negative  6  83  89  
Row Total  10  89  99  
P value Fishers Exact Test  0.0108  
 
Table 22:  Direct AFB smear in HIV and non HIV patients 
 
Figure 40: Direct AFB smear in HIV and non HIV patients 
In our study 40 % of HIV patients and 6% of HIV non reactive patients 
had positive smear for AFB by modified Ziehl-Neelson staining. 
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LJ culture in HIV And non HIV patients 
HIV Positivity Vs 
Culture Positivity  
Culture Positive  Culture Negative  Column Total  
HIV Positive  8  2  10  
HIV Negative  18  71  89  
Row Total  26  73  99  
P value Fishers Exact Test  0.0005  
 
Table  23: LJ culture showing MTB growth in HIV and non HIV patients 
 
Figure 41:  LJ culture showing MTB growth in HIV and non HIV patients 
In our study out of 10 HIV patients, 8(80%) showed growth in culture 
and among 89 non HIV patients 18 patients (20%) showed growth in culture. 
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Drug resistance pattern in HIV patients 
HIV Positivity Vs 
Drug Resistance  
Drug Sensitive  Drug Resistant  Column Total  
HIV Positive  6  3  9  
HIV Negative  12  5  17  
Row Total  18  8  26  
P value Fishers Exact Test  > 0.9999  
 
Table 24: Drug resistance in HIV and non HIV patients 
In our study out of 9 HIV patients who had MTB grown in LJ culture 3 
patients had drug resistant tuberculosis. And among patients seronegative for 
tuberculosis among 17 culture positive patients, 5 patients had drug resistant 
tuberculosis. 
 
Figure 42: Drug resistant lymph node and bone TB in HIV and     
non HIV patients 
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Figure 43:Percentage of drug resistant tuberculosis in HIV 
seropositive and seronegative patients 
In our study, we observed that 3 patients out of  9 HIV patients who had 
mycobacterium tuberculosis grown in LJ culture had resistance atleast to one 
antituberculous drug. 33% of culture positive lymph node and bone 
tuberculosis in HIV patients were resistant to atleast one of first line 
antituberculous drugs. 
Among HIV seronegative patients, among 17 patients who had growth 
in culture 5 cultures showed resistance to atleast one antituberculous drug. We 
observed that 29.4% of culture positive lymph node and bone tuberculosis in 
non HIV patients were resistant to atleast one of first line antituberculous 
drugs. 
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DISCUSSION 
This study included 114 patients of clinical suspects of lymph node 
(n=83) and bone tuberculosis (n= 31). 
Out of the 114 patients 92 patients had granulomas , 12 patients had non 
specific inflammation, 5 patients had carcinoma, 3 patients had lymphoma, 1 
patient had acute inflammation and 1 patient had necrotic tissue on 
histopathological examination of the biopsy specimens. 
It was observed LJ culture showed growth and isolates identified as 
Mycobacterium tuberculosis in 26  cases out of 114 cases. Out of 92 patients 
with granulomas on histopathology 19 were positive in LJ culture and out of 22 
patients with non granulomas on histopathology 7 were positive in LJ culture. 
This observation is consistent with culture yields in earlier studies. 
Definition for diagnosis of lymph node and bone tuberculosis: 
A patient was defined as having lymph node / bone tuberculosis if either 
granulomas were present in histopatology or LJ culture showed growth and identified 
as mycobacterium tuberculosis or both. 
19 cases were diagnosed as tuberculous based on both granulomas in 
histopathology and growth in LJ medium identified as Mycobacterium tuberculosis, 
73 cases based on granulomas  in histopathology alone and 7 cases based on LJ 
culture alone. 
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Out of 114 clinical suspects of lymph node and bone tuberculosis, 99 
were diagnosed as tuberculous, lymph node(n=74) and bone(n=25). 
Supportive evidence in lymph node and bone tuberculosis versus 
other diagnosis: 
The contributions of contact history, constitutional symptoms, anemia 
and elevated ESR in the clinical suspicion of lymph node and bone tuberculosis 
were analysed. 
It was observed that history of contact was present in 24 % of patients 
with tuberculosis and 20% of patients with other etiologies and constitutional 
symptoms were present in 81% of patients with tuberculosis and 80% of 
patients with other etiologies. 
It was observed that anemia was present in 60 % of patients with 
tuberculosis and 60 % of patients with other etiologies and elevated ESR in    
86 % of patients with tuberculosis and  87 % of patients with other diagnosis.  
It was observed that the supportive evidences are almost equally 
distributed among cases of tuberculosis and other clinical suspects excluded 
from the case definition. Hence they play a marginal role in separating 
tuberculosis from other diagnosis. 
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Age distribution: 
The peak age distribution observed in lymph node tuberculosis is 11 -20 
years (47.29%), closely followed by 21-30 years (40.5%). These two age 
groups together constitute nearly 88% of cases of lymph node tuberculosis in 
our study.  
The peak age distribution that we observed in bone tuberculosis is 31-40 
years (40%), followed by 21-30 years (32%). These two age groups constitutes 
72% of cases of bone tuberculosis. 
Both lymph node and bone tuberculosis is relatively less common in age 
greater than 40 years. It was observed that only 10% of lymph node 
tuberculosis occurs in age greater than 40 years and 24% of bone tuberculosis 
occurs in age greater than 40 years.  
The mean age of occurrence of lymph node tuberculosis and bone 
tuberculosis in our study is 25 years and 35 years respectively. 
Gender distribution: 
We observed a female preponderance in lymph node tuberculosis 
(63.51%) and male preponderance in bone tuberculosis (60%) which is 
statistically significant [p value -0.011]. 
In our study the ratio of male: female patients of 3 : 5.3 in lymph node 
tuberculosis and a male : female ratio of  3 : 2 in bone tuberculosis. 
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Sites of involvement in lymph node and bone tuberculosis: 
In our study, it was observed that  posterior cervical lymph node 
involvement was seen in 48%cases, anterior cervical in 42% cases, 
submandibular in 5% cases, axillary in 4% cases and inguinal in nearly 1%. 
In bone tuberculosis, it was that observed 68% cases of bone 
tuberculosis in lower thoracic spine, 24% cases in lumbar spine and 8% cases 
in upper thoracic spine. The anatomic distribution of lymph node and bone 
tuberculosis are consistent with those observed in previous studies reviewed 
earlier. 
Comparison of new patients and previously treated patients: 
In this study it was observed that 27% new patients and 11.1% 
previously treated patients had history of contact with sputum positive case of 
pulmonary tuberculosis. 
It was observed that constitutional symptoms were present in 71 out of 
81 new patients (87.65%) of lymph node and bone tuberculosis and in all the 
previously treated patients. 
It was observed that 60% of new patients and 61.1% of previously 
treated patients of lymph node and bone tuberculosis had haemoglobin 
concentration of less than 12 gram/dl. 
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In this study, it was observed that 85 % (n=85) of patients of lymph 
node and bone tuberculosis had ESR>40 mm Hg. 
It was observed that 7% of new patients(6 out of 81) and 33% of 
previously treated patients (6 out of 18)  had positive smear for acid fast 
bacillus by modified Ziehl- Neelson staining and the difference is statistically 
significant.[p=0.0066]  
In this study 9 out of 18(50%) previously treated patients had positive 
culture in LJ medium and identified as mycobacterium tuberculosis. 17 out of 
81(20.98%) of new patients had positive culture and the difference is 
statistically  significant.[p=0.0055]  
It is inferred from the above two observations that the bacillary load is 
higher in previously treated patients compared to new patients 
In this study 14 patients out of 17 new patients had drug sensitive 
tuberculosis and 4 out of 9 previously treated patients had drug sensitive 
tuberculosis. The drug resistance is 17.6% in new and 55.5 % in previously 
treated patients. 
Pattern of drug resistance: 
Out of 26 patients with culture positive results, 18 patients had drug 
sensitive tuberculosis. Among the 8 patients who had drug resistant 
tuberculosis, two had multidrug resistance (resistance to isoniazid and 
rifampicin) two had poly drug resistance(resistance to more than one 
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antituberculous drug other than combination of isoniazid and rifampicin) and 
four had mono drug resistance( resistance to only one first line antituberculous 
drug). 
Of the eight patients with drug resistance, six patients had lymph node 
tuberculosis and two patients had bone tuberculosis. Of the drug resistant 
lymph node tuberculosis, one patient had multidrug resistant tuberculosis, three 
patients had mono drug resistance and two patients had poly drug resistance.  
Of the two patients with drug resistant bone tuberculosis, one had 
multidrug resistant tuberculosis and one had mono drug resistance.  
Our results with reference to drug resistance in extra pulmonary 
tuberculosis were a little different from the study from North India by AK 
Maurya et al36., where they observed that 61.8% of new cases were susceptible 
to all drugs and 57.2% of previously treated cases were susceptible to all drugs. 
They observed that monoresistance and resistance to two drugs were more 
common in new cases whereas resistance to three drugs and resistance to four 
drugs were more common in previously treated cases. They observed that on 
the whole 39.9% of extrapulmonary tuberculosis cases were resistant to first 
line anti-tubercular drugs 
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Diabetes mellitus as a comorbidity in lymph node and bone 
tuberculosis: 
In the study population 16% of the new cases had diabetes and none of 
previously treated cases had diabetes. 
It was observed that constitutional symptoms were present in 5 out of  
the 9 diabetic  patients in our study. Among the non diabetics, out of  90 
patients 84  had constitutional symptoms.  
Constitutional symptoms were present in 55.55% of diabetics and 
93.33% of non diabetics. There is a difference in the occurrence of 
constitutional symptoms in patients of lymph node and bone tuberculosis if 
diabetes is a co morbid illness and the difference is statistically 
significant.[p=0.0012] 
It was observed that in 1 out of 9 diabetics direct smear for AFB was 
positive and in 11 out of 90 non diabetics direct smear for AFB was positive. 
It was observed that 3 out of 9 diabetic patients (33.33%) had 
mycobacterium tuberculosis grown in culture and 23 out of 90 non diabetics 
(25.55%) had positive growth in LJ culure. 
It was observed that out of 3 diabetic patients who had growth in culture 
2 patients had drug sensitive tuberculosis and 1 patient had drug resistant 
tuberculosis. 
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HIV in lymph node and bone tuberculosis: 
In this study, there were 7 HIV seropositive patients among new patients 
and 3 HIV seropositive patients among previously treated patients of  lymph 
node and bone tuberculosis. 8 out of 10 HIV patients(80%) had constitutional 
symptoms and 81 out of 89 non HIV patients(91.01%) had constitutional 
symptoms. Out of 10 HIV patients, 6(60%)did not show granulomas in 
histopathology. Among 89 patients who are seronegative for HIV 1(0.01%) did 
not show granuloma in histopathology. 
In this study  40 %  of  HIV patients and 6% of  HIV non reactive 
patients had positive smear for AFB by modified Ziehl-Neelson staining. Out 
of 10 HIV patients, 8(80%) showed growth in culture and among 89 non HIV 
patients 18 patients(20%) showed growth in culture.It is inferred that bacillary 
load is higher in HIV patients. 
In this study, we observed that 3 patients out of  9 HIV patients who had  
mycobacterium tuberculosis grown in LJ culture had resistance atleast to one 
antituberculous drug. 33% of culture positive lymph node and bone 
tuberculosis in HIV patients were resistant to atleast one of first line 
antituberculous drugs. 
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Among HIV seronegative patients, 17 patients who had growth in 
culture 5 cultures showed resistance to atleast one antituberculous drug. We 
observed that 29.4% of culture positive lymph node and bone tuberculosis in 
non HIV patients were resistant to atleast one of first line antituberculous 
drugs. 
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CONCLUSION 
1. The case definition based on histology and microbiology was met 
by 86.8% of clinical suspects of lymph node and bone 
tuberculosis. 
2. Most of the patients of lymph node tuberculosis were in the age 
group of 11-20 years and of bone tuberculosis were in the age 
group of 31-40 years. 
3. Lymph node tuberculosis was more common in females with a 
male to female ratio of 3:5 and bone tuberculosis more common 
in males with a male to female ratio of 3:2. 
4. There was histopathological evidence of granulomas in 80% of 
clinical suspects of lymph node and bone tuberculosis. 
5. Mycobacterium tuberculosis was isolated from 22% of clinical 
suspects of lymph node and bone tuberculosis. 
6. Of the culture isolates 23% showed non granulomas in histology, 
of these 60% were HIV seropositive and 40% diabetic. It is 
inferred that immune suppression interferes with eliciting a 
granulomatous response and hence in patients with immune 
suppression tuberculosis should be considered even in the 
absence of granulomas in histology. 
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7. The multi drug resistance rate was 22% in previously treated 
patients compared to none of the new patients. 
8. The resistance rate in HIV patients was 37.5% and in HIV 
negative patients was 27.7%. 
9. Lymph node and bone tuberculosis have a higher degree of drug 
resistance in previously treated patients and HIV seropositive 
patients. These groups can be considered as risk factors for drug 
resistance in lymph node and bone tuberculosis and can be 
targeted for drug susceptibility testing (DST). 
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LIMITATIONS OF THE STUDY 
 
1. The sample sizes of lymph node and bone tuberculosis are not equally 
distributed. Hence the results pertaining to culture yield and drug 
resistance cannot be interpreted giving equal weightage among the two 
groups. 
2. Bone tuberculosis is represented only by tuberculosis of the spine. 
3. There may be a selection bias because of the large proportion of referred 
cases reporting to our tertiary care hospital and the resistance rates 
cannot be extrapolated to the community at large. 
4. The etiology of granulomas could be varied and is not specific to 
mycobacterium tuberculosis. Hence there is a possibility of 
overdiagnosis of mycobacterium tuberculosis. 
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 ABBREVIATIONS 
MTB   – Mycobacterium tuberculosis 
MDR   –  Multi Drug Resistant 
XDR   –  Extremely Drug Resistant 
AFB   – Acid Fast Bacillus 
LJ medium  –  Lowenstein Jensen medium 
SK medium – Selective Kirschner’s medium 
HIV   –  Human Immunodeficiency Virus 
NIRT   –  National Institute for Research in Tuberculosis 
HPE   – Histo Pathological Examination 
 
 
 
 
 
 
 
  
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 PATIENT INFORMATION SHEET 
 
TITLE OF THE STUDY: “Clinical and bacteriological profile in lymph node and 
bone tuberculosis” 
 
We are conducting a study on  patients admitted in Rajiv Gandhi Government General 
Hospital, Chennai. 
  
The purpose of this study is to study the clinical and and bacteriological 
characterisitics in patients with lymph node and bone tuberculosis. 
 
We are selecting patients with lymph node/ bone tuberculosis in whom the treating 
doctor has suggested surgical intervention for diagnostic/therapeutic purposes. We 
collect sociodemographic details, clinical examination findings, relevant blood 
investigations and surgical specimens for histopathological and microbiological 
examination including culture for mycobacterium tuberculosis at national reference 
laboratory. 
  
The  privacy  of  the  patients  in  the  research  will  be  maintained   throughout   the 
study. In the event of any publication or presentation resulting from the research, no 
personally identifiable information will be shared. 
  
Taking part in this study is voluntary.  You  are  free  to  decide  whether  to  
participate in this  study  or  to  withdraw  at  any  time;  your  decision  will  not  
result  in any  loss of  benefits to which  you  are  otherwise  entitled.  
 
The  results  of  the  special  study  may  be  intimated  to  you  at  the  end  of the 
study period  or during   the study if  anything  is found  abnormal  which  may  aid  in  
the  management  or treatment. 
 
Signature of Investigator    Signature of Participant 
 
Date : 
 PATIENT CONSENT FORM 
 
Study Detail : “Clinical and bacteriological profile in 
lymph node and bone tuberculosis” 
Study Centre : Rajiv Gandhi Government General 
Hospital, Chennai. 
Patient’s 
Name 
:  
Patient’s Age :  
Identification 
Number 
:  
Patient may check (√) these boxes 
a) I confirm that I have understood the purpose of procedure for the 
above study. I have the opportunity to ask question and all my 
questions and doubts have been answered to my complete 
satisfaction.  
b) I understand that my participation in the study is voluntary and 
that I am free to withdraw at any time without giving reason, 
without my legal rights being affected.  
c) I understand that sponsor of the clinical study, others working on 
the sponsor’s behalf, the ethical committee and the regulatory 
authorities will not need my permission to look at my health 
records, both in respect of current study and any further research 
that may be conducted in relation to it, even if I withdraw from the 
study I agree to this access. However, I understand that my 
identity will not be revealed in any information released to third 
parties or published, unless as required under the law. I agree not 
to restrict the use of any data or results that arise from this study.  
d) I agree to take part in the above study and to comply with the 
instructions given during the study and faithfully cooperate with 
the study team and to immediately inform the study staff if I suffer 
from any deterioration in my health or well-being or any 
unexpected or unusual symptoms.  
e) I hereby consent to participate in this study.  
f) I hereby give permission to undergo detailed clinical examination, 
Radiographs, blood investigations and surgical procedure as 
required.  
Signature of Investigator    Signature of Participant 
 
Date &time :      Name and address 
 
Place: 
  
  
 
 PROFORMA 
Name    
Age    
Sex    
IP/OP Number   
Address   
Clinical History  
Presenting complaints 
Duration of symptoms 
History of constitutional symptoms 
History of contact with sputum positive case of tuberculosis 
Previous history of treatment for tuberculosis/ history of diabetes mellitus and 
other comorbid illness. 
Clinical Examination: 
 
 
 
 Investigations: 
For all patients 
 Chest  X ray PA view 
 Hemogram 
 Random Blood Sugar 
 HIV antibody testing 
If indicated 
 Fasting Blood Sugar 
 Postprandial Blood Sugar 
 Renal Function Test 
 Liver Function Test 
 Sputum for Acid Fast Bacilli 
 Ultrasonogram Abdomen/Neck 
 X ray Lumbo sacral/dorsal spine 
 MRI Spine 
 Histopathological Examination: 
Microbiological Examination: 
Direct Smear for AFB: 
 
LJ Culture: 
 
Drug Sensitivity Pattern: 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
